BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11937581)

  • 1. Two distinctly HLA-associated contiguous linear epitopes uniquely expressed within the islet antigen 2 molecule are major autoantibody epitopes of the diabetes-specific tyrosine phosphatase-like protein autoantigens.
    Bearzatto M; Naserke H; Piquer S; Koczwara K; Lampasona V; Williams A; Christie MR; Bingley PJ; Ziegler AG; Bonifacio E
    J Immunol; 2002 Apr; 168(8):4202-8. PubMed ID: 11937581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody 76F distinguishes IA-2 from IA-2beta and overlaps an autoantibody epitope.
    Piquer S; Valera L; Lampasona V; Jardin-Watelet B; Roche S; Granier C; Roquet F; Christie MR; Giordano T; Malosio ML; Bonifacio E; Laune D
    J Autoimmun; 2006 May; 26(3):215-22. PubMed ID: 16503116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4.
    Peakman M; Stevens EJ; Lohmann T; Narendran P; Dromey J; Alexander A; Tomlinson AJ; Trucco M; Gorga JC; Chicz RM
    J Clin Invest; 1999 Nov; 104(10):1449-57. PubMed ID: 10562307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.
    Miao D; Yu L; Tiberti C; Cuthbertson DD; Rewers M; di Mario U; Eisenbarth GS; Dotta F
    J Autoimmun; 2002 Mar; 18(2):191-6. PubMed ID: 11908951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes.
    Farilla L; Tiberti C; Luzzago A; Yu L; Eisenbarth GS; Cortese R; Dotta F; Di Mario U
    Eur J Immunol; 2002 May; 32(5):1420-7. PubMed ID: 11981830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of HLA-DR and -DQ alleles on autoantibody recognition of distinct epitopes within the juxtamembrane domain of the IA-2 autoantigen in type 1 diabetes.
    Richardson CC; McLaughlin KA; Morgan D; Feltbower RG; Christie MR
    Diabetologia; 2016 Feb; 59(2):334-40. PubMed ID: 26564179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiobinding assay for detecting autoantibodies to single epitopes.
    Lampasona V; Belloni C; Piquer S; Bonicchio S; Furlan R; Bonifacio E
    J Immunol Methods; 2008 Jul; 336(2):127-34. PubMed ID: 18501377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine mapping of diabetes-associated IA-2 specific autoantibodies.
    Bearzatto M; Lampasona V; Belloni C; Bonifacio E
    J Autoimmun; 2003 Dec; 21(4):377-82. PubMed ID: 14624760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes.
    Kelemen K; Gottlieb PA; Putnam AL; Davidson HW; Wegmann DR; Hutton JC
    J Immunol; 2004 Mar; 172(6):3955-62. PubMed ID: 15004204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR4-associated T and B cell responses to specific determinants on the IA-2 autoantigen in type 1 diabetes.
    McLaughlin KA; Gulati K; Richardson CC; Morgan D; Bodansky HJ; Feltbower RG; Christie MR
    J Immunol; 2014 Nov; 193(9):4448-56. PubMed ID: 25225671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients.
    Blancou P; Mallone R; Martinuzzi E; Sévère S; Pogu S; Novelli G; Bruno G; Charbonnel B; Dolz M; Chaillous L; van Endert P; Bach JM
    J Immunol; 2007 Jun; 178(11):7458-66. PubMed ID: 17513797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
    Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICA12 autoantibodies are associated with non-DR3/non-DR4 in patients with latent autoimmune diabetes in adults from northern India.
    Gupta M; Tandon N; Shtauvere-Brameus A; Sanjeevi CB
    Ann N Y Acad Sci; 2002 Apr; 958():329-32. PubMed ID: 12021135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
    Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC
    J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans.
    Härkönen T; Paananen A; Lankinen H; Hovi T; Vaarala O; Roivainen M
    J Med Virol; 2003 Mar; 69(3):426-40. PubMed ID: 12526055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IA-2 combined epitope assay: a new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes.
    Tiberti C; Verrienti A; Fiore B; Yu L; Eisenbarth GS; Dotta F; Di Mario U
    Clin Immunol; 2005 Jun; 115(3):260-7. PubMed ID: 15893693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of epitopes for autoantibodies to the type 1 diabetes autoantigen IA-2 by peptide phage display and molecular modeling: overlap of antibody and T cell determinants.
    Dromey JA; Weenink SM; Peters GH; Endl J; Tighe PJ; Todd I; Christie MR
    J Immunol; 2004 Apr; 172(7):4084-90. PubMed ID: 15034020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IA-2 antibody isotypes and epitope specificity during the prediabetic process in children with HLA-conferred susceptibility to type I diabetes.
    Hoppu S; Härkönen T; Ronkainen MS; Simell S; Hekkala A; Toivonen A; Ilonen J; Simell O; Knip M
    Clin Exp Immunol; 2006 Apr; 144(1):59-66. PubMed ID: 16542366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse.
    Koczwara K; Schenker M; Schmid S; Kredel K; Ziegler AG; Bonifacio E
    Clin Immunol; 2003 Feb; 106(2):155-62. PubMed ID: 12672406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.